Xiangxue Pharmaceutical: Kunlun Investment, the controlling shareholder, releases 18.97 million shares of pledge

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Comments are closed.